Sep 17, 2020, 16:20 PM by Michael Croft

CARLSBAD, CA, UNITED STATES - Sep 17, 2020 - Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced the commercial launch of its CRISPRclean™ technology

Sep 17, 2020, 13:45 PM by Michael Croft

Bio-IT World Disease treatment through targeted protein degradation takes a range of approaches: from small molecules similar to thalidomide that act as “molecular glue” degraders to more advanced “beyond rule of 5” proteolysis-targeting chimeras (PROTACs) with bifunctional moieties that encourage protein interaction with its E3 ubiquitin ligase.

Sep 17, 2020, 09:49 AM by Michael Croft

BAR HARBOR, ME, UNITED STATES - Sep 17, 2020 - The MDI Biological Laboratory has announced that Romain Madelaine, Ph.D., has been appointed to the faculty as an assistant professor

Sep 17, 2020, 07:12 AM by Michael Croft

ROCHESTER, NY, UNITED STATES - Sep 17, 2020 - The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R

Sep 16, 2020, 15:45 PM by Michael Croft

JENA, GERMANY - Sep 2, 2020 - Materials and Life Science researchers can now experience faster accessibility of deeper regions of interest when investigating samples in 3D

Sep 16, 2020, 11:51 AM by Michael Croft

RALEIGH, NC, UNITED STATES - Sep 16, 2020 - Fierce Healthcare released its annual Fierce Innovation Report this week, naming 2bPrecise the industry’s top clinical information management solution

Sep 16, 2020, 08:56 AM by Michael Croft

PHILADELPHIA, PA - Sep 16, 2020 - Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, today announced the appointment of Wendy DiCicco to its board of directors

Sep 16, 2020, 01:20 AM by Michael Croft

Bio-IT World  The adoption of cloud technology in the life science industry has become increasingly pervasive as firms move forward with digital transformation initiatives aimed at creating operational efficiencies and delivering the next wave of biomedical innovations. As a result, cloud vendors are playing a more important role than ever before, especially for life sciences companies that produce FDA-regulated products.

Sep 15, 2020, 15:50 PM by Michael Croft

PHOENIX, AZ - Sep 15, 2020 - Accumen Inc. is helping healthcare get better, faster. Today the company launched its first software-as-a-service (SaaS) solution, MyBloodHealth®, a hospital-based telehealth anemia management program with both perioperative and comprehensive blood management options

Sep 15, 2020, 11:18 AM by Michael Croft

TORONTO, ON, CANADA - Sep 15, 2020 -  With advances in imaging technologies, new wearable health devices, mobile devices allowing patients to provide survey responses everywhere, and increasingly integrated electronic health records, health data consented for advancing biomedical research has never been more plentiful – or complex

Sep 15, 2020, 11:15 AM by Michael Croft

Bio-IT World VAST Data has launched its next generation storage architecture, LightSpeed, which combines the light-touch of VAST’s simple NAS appliance experience with leadership-class performance for GPU-based and AI Processor-based computing, taking the guesswork and configuration out of scaling up AI infrastructure.

Sep 15, 2020, 09:55 AM by Michael Croft

BOSTON, MA, UNITED STATES - Sep 15, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and Cerner Corporation, a global healthcare technology company, today announced that Adventist Health, a faith-based, nonprofit integrated health system serving the West Coast and Hawaii, has enhanced its digital consumer access experience with integrated technology solutions from the two companies

Sep 15, 2020, 09:42 AM by Michael Croft

REDCAR, UNITED KINGDOM - Sep 15, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of the SeqPack™ Hybridoma Preservation Kit, which streamlines the sample submission process for hybridoma sequencing customers worldwide

Sep 15, 2020, 06:16 AM by Michael Croft

CARY, NC - Sep 15, 2020 - For Immediate ReleaseCATO SMS ACQUIRES ARRAY BIOSTATISTICSGlobal Provider Expands Specialized Clinical Research Offering with Enhanced Biostatistical ServicesCARY, Nx

Sep 15, 2020, 03:50 AM by Michael Croft

SHIRLEY, NY, UNITED STATES - Sep 15, 2020 - Profacgen, a state-of-the-art protein service provider based in New York, established its own bioinformatics platform, which has emerged as a very sophisticated scientific infrastructure for bioinformatics involving computational facilities, to help explore, understand and analyze complex biological data in various biotechnological programs and projects

Sep 14, 2020, 10:25 AM by Michael Croft

CAMBRIDGE, MA, UNITED STATES - Sep 14, 2020 - HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in immunomodulation, today announced a partnership agreement with South Korea-based ABL Bio to advance HFB30132A, a SARS-CoV-2 neutralizing antibody for the treatment of COVID-19 patients

Sep 14, 2020, 09:35 AM by Michael Croft

LONDON, UNITED KINGDOM - Sep 14, 2020 - WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU

Sep 14, 2020, 05:48 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Sep 14, 2020 - Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing together all of its cancer services onto one platform

Sep 14, 2020, 01:25 AM by Michael Croft

Bio-IT World | NIH contracts to explore radiation countermeasures, Alzheimer’s medication, and convalescent plasma, Mission Bio gets $70M for single cell multi-omics technology, and more.

Sep 11, 2020, 06:20 AM by Michael Croft

Bio-IT World  | Japanese researchers argue there is no cytokine storm, computer-designed protective proteins, ELISA test for antibodies, COVID-19’s impact on Black and Hispanic communities, a “burstier” model of disease spread, and new biomarkers for elevated risk. Plus, the International Vaccine Institute preps with Gates money, 3M funds vaccine researcher, and more.